Martin Makary

arrow back backwards u-turn turn around reverse
Favicon Fierce Pharma

Hims quits on obesity pill after legal, regulatory heat

Hims has quickly retreated from its launch of a compounded obesity pill after facing mounting pressure from the FDA and Novo Nordisk.
Fraiser Kansteiner Feb 9, 2026 10:24am
Makary
Favicon Fierce Pharma

FDA commissioner pledges crackdown on compounding practices

Feb 6, 2026 9:59am
FDA
Favicon Fierce Pharma

FDA takes close look at mifepristone REMS program

Sep 25, 2025 11:00am
FDA
Favicon Fierce Pharma

FDA urges doctors to minimize Tylenol use during pregnancy

Sep 23, 2025 8:55am
Pfizer
Favicon Fierce Pharma

Pfizer, Moderna score updated COVID vaccine approvals from FDA

Aug 27, 2025 3:26pm
women gender womens health International Womens Day
Favicon Fierce Biotech

Biotech leaders urge FDA to not restrict abortion pill access

Jul 2, 2025 2:14pm